Assistant Professor, Medicine, University of Miami School of Medicine
Nephrology
Dr. Alessia Fornoni, MD
|
|
Give Review
Doctor Alessia Fornoni, MD is an expert in the field of Nephrology. She received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (ASNF)". Doctor Alessia Fornoni, MD is also published. She has 67 publications published. The lastest publication: "Stimulation of hepatocyte growth factor in human acute renal failure.' Alessia Fornoni accepts all Medicare patients.
Publications
- Tissue-Engineered Microvasculature to Reperfuse Isolated Renal Glomeruli.
- Nonimmunologic targets of immunosuppressive agents in podocytes.
- Insulin signaling: implications for podocyte biology in diabetic Kidney disease.
- A circulating antibody panel for pretransplant prediction of FSGS recurrence after Kidney transplantation.
- Lipid biology of the podocyte-new perspectives offer new opportunities.
- Sphingomyelinase-Like Phosphodiesterase 3b Expression Levels Determine Podocyte Injury Phenotypes in Glomerular Disease.
- Podocyte foot process effacement in postreperfusion allograft biopsies.
- Issues in solid-organ transplantation in children: translational research from bench to bedside.
- Rituximab: a boot to protect the foot.
- Diabetic nephropathy: Is it time yet for routine Kidney biopsy?
- Cyclodextrin protects podocytes in diabetic Kidney disease.
- Abatacept in B7-1-Positive Proteinuric Kidney Disease.
- In Vivo 17β-Estradiol Treatment Contributes to Podocyte Actin Stabilization in Female db/db Mice.
- An unusual presentation of tumor lysis syndrome in a patient With advanced gastric adenocarcinoma: case report and literature review.
- In vivo imaging of Kidney glomeruli transplanted into the anterior chamber of the mouse eye.
- Low insulin-like growth factor binding protein-2 expression is responsible for increased insulin receptor substrate-1 phosphorylation in mesangial cells from mice susc...
- Defining the role of mycophenolate mofetil in the treatment of proliferative lupus Nephritis.
- Barriers to successful care for chronic Kidney disease.
- Metabolic Syndrome and endothelial dysfunction.
- Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
- Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased...
- Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors.
- Glucose induces clonal selection and reversible dinucleotide repeat expansion in mesangial cells isolated from glomerulosclerosis-prone mice.
- Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter With glomerulosclerosis susceptibility in mice.
- Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation.
- Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background.
- Combination therapy With renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?
- The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart Failure.
- The l-isoform but not d-isoforms of a JNK inhibitory peptide protects pancreatic beta-cells.
- Chronic Kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey.
- Overutilization of central venous catheters in incident hemodialysis patients: reasons and potential resolution strategies.
- Nonpharmacologic therapy for Hypertension: does it really work?
- Renin-angiotensin system blockade and Diabetes: moving the adipose organ from the periphery to the center.
- Riboflavin inhibits IL-6 expression and p38 activation in islet cells.
- Impact of pancreatic cold preservation on rat islet recovery and function.
- 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 Diabetes.
- Fibulin-5 expression is decreased in women With anterior vaginal wall prolapse.
- Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental Diabetes.
- Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
- Podocytopathy in Diabetes: a metabolic and endocrine disorder.
- Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
- Role of mTOR in podocyte function and diabetic Nephropathy in humans and mice.
- Proteinuria in Diabetes: an endocrine disease?
- Proteinuria, the podocyte, and insulin resistance.
- Reversible bone pain and symmetric bone scan uptake in a dialysis patient treated With cinacalcet: a case report.
- Differential expression of smooth muscle regulatory proteins in the uterosacral ligaments of women With uterine prolapse.
- Prolactin supplementation to culture medium improves beta-cell survival.
- Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release.
- Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.
- Caldesmon expression is decreased in women With anterior vaginal wall prolapse: a pilot study.
- Role of inflammation in diabetic Nephropathy.
- Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.
- Effects of pancreas cold ischemia on islet function and quality.
- c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.
- Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death.
- beta-Cell specific cytoprotection by prolactin on human islets.
- New directions in the management of severe lupus Nephritis.
- Outcomes in African Americans and Hispanics With lupus nephritis.
- Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors.
- Cyclosporin A affects extracellular matrix synthesis and degradation by mouse MC3T3-E1 osteoblasts in vitro.
- Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.
- Matrix accumulation in mesangial cells exposed to cyclosporine A requires a permissive genetic background.
- Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures.
- Risk factors for Chronic renal dysfunction in cardiac allograft recipients.
- Stimulation of hepatocyte growth factor in human Acute renal failure.
- Volume-dependent factors in hypertension in chronic renal Failure.
Schools
Universita Degli Studi Di Pavia Facolta Di Medicina E Chirurgia
Jackson Meml Hospital University Miami
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (ASNF)
Education
-
Jackson Memorial Hospital - Jackson Health System -
University of Pavia Faculty of Medicine
Hospital
-
Miami Veterans Affairs Healthcare System -
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1891724118 | |
| NPPES Provider LastName | FORNONI | |
| NPPES Provider FirstName | ALESSIA | |
| NPPES Provider ZIPCode | 331361005 | |
| NPPES Provider State | FL | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 203.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891724118 |
| Last Name Of The Provider | FORNONI |
| First Name Of The Provider | ALESSIA |
| View All |
Similar Doctors
|
Dr. Gaspar A. Barreto Torrella, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jorge C. Busse, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael T. Lemont, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurence B. Gardner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alba M. Gonzalez-Ochoa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jorge M. Diego, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David S. Hoffman, MD |
|
|
Dr. Guibel Perera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Preston, MD |
|
|
Dr. Arif Asif, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rao A. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosana De Los Santos, MD |
|
|
Dr. Anne Marie V. Miles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ivonne H. Schulman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vijayachitra Madhanasekaran, MD |